Table 3

Disease-free survival and prognostic risk factor analysis

Prognostic risk factorPatients (n)Recurrences (n)DFS (%)P value
Lymph node
 Negative1151190.43NS
 Positive24291.66
Histology
 Adenocarcinoma39294.87NS
 Squamous1001189.00
Tumor size (cm)
 0–260591.67NS
 2.1–352590.38
 3.1–422386.36
 NA5
FIGO stage
 IA1 LVSI+50100.00NS
 IA2110100.00
 IB11141289.47
 Other*9188.88
LSVI
 No871088.51NS
 Yes49393.87
 NA3
Pre-operative brachytherapy
 No1171190.59NS
 Yes22290.90
Age (years)
 18–4057296.490.01
 41–4944393.18
 ≥5038878.94
  • *Nine patients with pre-operative stage IB1 tumor and stage IB2 or IIB tumor at final pathology.

  • DFS, disease-free survival;LVSI, lymph-vascular space involvment;NA, not available;NS, non-significant.